circRNA basic information
circBase ID: hsa_circ_0000437
Name: hsa_circ_CORO1C
Synonym: -
Host Gene: CORO1C
Genomic location(hg19): chr12:109046047-109048186:-
Genomic location(hg38): chr12:108652271-108654410:-
Subcellular localization: nucleus; exosome
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0001056
MONDO name: gastric cancer
Disease details: gastric cancer
Disease DO ID:
10534
Disease MeSH ID:
-
Disease NCIt ID:
C9331
Disease ICD11 ID:
1397617262
Disease OMIM ID:
613659
Species: Human
Species details: Homo sapiens
Tissue specimen:

GC tissues; corresponding non-tumor tissue; para-cancer tissues; serum; serum exosomes; peripheral blood

Cell lines:

BGC-823; HGC-27; MKN-1; MKN-45; GES-1; HLECs

In vivo animal model:

cell line-derived xenograft

circRNA-disease information
Expression pattern:
UP
Associated gene: SRSF3, PDCD4, PDCD4 mRNA, HSPA2, ERK1/2, p-ERK, MMP-2, LYVE-1, ICAM-1
Associated microRNA: -
Biological function: Promotes GC cell proliferation, invasion, migration and tumor growth; inhibits apoptosis; promotes HLEC migration, invasion and tube formation; promotes lymphangiogenesis and lymph node metastasis.
Molecular mechanism: Protein interaction mechanism: hsa_circ_0000437 binds SRSF3 to suppress PDCD4 expression and promote GC growth; exosomal hsa_circ_0000437 binds HSPA2 and activates ERK signaling in HLECs independently of VEGF-C to promote lymphangiogenesis and LNM.
Biological pathway or process:

ERK (promotes); proliferation (promotes); migration (promotes); invasion (promotes); apoptosis (inhibits); metastasis (promotes); angiogenesis (promotes); other pathway/process (promotes)

Detected method:
Q
S
Validation methods:

Back-Splice Junction PCR / divergent primers PCR; Sanger Sequencing; circRNA-seq; RT-qPCR; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; Clinical Sample Validation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Tube Formation Assay; In Vivo Animal Model; H&E Staining; IHC (Immunohistochemistry); Western Blot; Survival Analysis; ROC Analysis; Bioinformatics Analysis

Clinical significance:

Serum exosomal hsa_circ_0000437 is enriched in GC patients, associated with LNM, T stage, N stage and differentiation, discriminates GC patients from healthy controls and GC patients with LNM from those without LNM, and high serum exosomal hsa_circ_0000437 is associated with poor survival outcomes.

Description:

hsa_circ_0000437 is a CORO1C-derived circRNA upregulated in gastric cancer tissues, cells and serum exosomes. It promotes GC tumorigenic phenotypes through the SRSF3/PDCD4 axis and promotes lymphangiogenesis and lymph node metastasis via exosomal transfer to HLECs and HSPA2-ERK signaling. Clinically, high serum exosomal hsa_circ_0000437 is associated with LNM and poor survival and may serve as a diagnostic/prognostic biomarker and therapeutic target.

Confidence score:

0.8824

Other information
Title:

Hsa_circ_0000437 promotes pathogenesis of gastric cancer and lymph node metastasis.

Journal: Oncogene
Published: 2022
PubMed ID: 36109630
Study type:

combined biological and clinical study

Data availability: Supplementary Information; https://doi.org/10.1038/s41388-022-02449-w; Circbase database (http://www.circbase.org/)
Code availability: -